ALA 3.45% 15.0¢ arovella therapeutics limited

ABLM That though did run through my head "another mouth to feed"...

  1. 8,592 Posts.
    lightbulb Created with Sketch. 1654
    ABLM

    That though did run through my head "another mouth to feed" but then I said maybe I had better not post that and give the man a chance to see what he can deliver.

    After reading the item on AYTU and Zolpimist I keep asking myself why haven't SUDA at least submitted a MAA for it in Australia.

    Can you imagine what our share price might do if they could get a MAA for Zolpimist here in Australia, even if either TEVA or Eddingpharm coud get approval in their licensed Territories.

    We need to get one of our products approved and commercialised and revenue flowing in, we also need regular updates on just how the number of discussions with so called big pharmas are actually progressing.

    Why have we not heard about the 21 June 2017 with the MHRA

    "The proposed regulatory dossier is intended to support a marketing authorisationapplication to either the MHRA or the European Medicines Agency. Furthermore, SUDAwill be seeking advice from the MHRA on the acceptability of the excipients used in theZolpiMist oral spray formulation which are all listed in the US pharmacopeia."

    So maybe this impressive team you state SUDA are building will somehow get things moving.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
0.005(3.45%)
Mkt cap ! $138.7M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $301.1K 2.087M

Buyers (Bids)

No. Vol. Price($)
3 79105 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 357820 9
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
14.5¢
  Change
0.005 ( 2.84 %)
Open High Low Volume
14.5¢ 15.0¢ 14.0¢ 441083
Last updated 15.34pm 29/03/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.